Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IB-IIIB NSCLC”

67 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 67 results

Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Study completedNCT02154399
What this trial is testing

EF5 in Measuring Tumor Hypoxia in Patients With Stage I-III Non-Small Cell Lung Cancer

Who this might be right for
Stage IA Non-Small Cell Lung CarcinomaStage IB Non-Small Cell Lung CarcinomaStage IIA Non-Small Cell Lung Carcinoma+3 more
National Cancer Institute (NCI) 28
Not applicableActive Not RecruitingNCT02194738
What this trial is testing

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

Who this might be right for
Stage IB Lung Non-Small Cell Carcinoma AJCC v7Stage II Lung Non-Small Cell Cancer AJCC v7Stage IIA Lung Cancer AJCC v8+4 more
National Cancer Institute (NCI) 8,300
Early research (Phase 1)Study completedNCT02364609
What this trial is testing

Pembrolizumab and Afatinib in Patients With Non-small Cell Lung Cancer With Resistance to Erlotinib

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage IIIA Non-Small Cell Lung CancerStage IIIB Non-Small Cell Lung Cancer+1 more
Jonathan Riess 11
Not applicableWithdrawnNCT05412875
What this trial is testing

Pilot Trial of E Cigarettes in Pts Diagnosed With Cancer of the Head, Neck, and Lung

Who this might be right for
Head and Neck Squamous Cell CarcinomaLung Non-Small Cell CarcinomaStage I Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8+15 more
Ohio State University Comprehensive Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT05017025
What this trial is testing

Aurora Kinase Inhibitor LY3295668 in Combination With Osimertinib for the Treatment of Advanced or Metastatic EGFR-Mutant Non-squamous Non-small Cell Lung Cancer

Who this might be right for
Advanced Lung Non-Squamous Non-Small Cell CarcinomaMetastatic Lung Non-Squamous Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8+6 more
M.D. Anderson Cancer Center 32
Early research (Phase 1)Active Not RecruitingNCT02321501
What this trial is testing

Ceritinib and Everolimus in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIB-IV Non-small Cell Lung Cancer

Who this might be right for
ALK PositiveLocally Advanced Malignant Solid NeoplasmMetastatic Malignant Solid Neoplasm+3 more
M.D. Anderson Cancer Center 37
Testing effectiveness (Phase 2)Study completedNCT01262560
What this trial is testing

Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer

Who this might be right for
DysphagiaLung CancerPain+1 more
Radiation Therapy Oncology Group 163
Testing effectiveness (Phase 2)Ended earlyNCT00958321
What this trial is testing

Positron Emission Tomography and Computed Tomography in Planning Treatment for Patients Undergoing 3-Dimensional Conformal Radiation Therapy for Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery. ICORG 06-35

Who this might be right for
Lung CancerMetastatic Cancer
Cancer Trials Ireland 40
Not applicableStudy completedNCT02728596
What this trial is testing

S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)

Who this might be right for
Febrile NeutropeniaStage 0 Breast CancerStage 0 Colorectal Cancer+25 more
SWOG Cancer Research Network 3,665
Early research (Phase 1)Study completedNCT03590054
What this trial is testing

Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor Malignancies

Who this might be right for
Stage III Cutaneous MelanomaStage IV Cutaneous MelanomaLocally Advanced Melanoma+18 more
Rahul Aggarwal 35
Early research (Phase 1)Study completedNCT01457469
What this trial is testing

Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung Cancer

Who this might be right for
Limited Stage Small Cell Lung CancerRecurrent Small Cell Lung CancerStage IA Non-small Cell Lung Cancer+6 more
Wake Forest University Health Sciences 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT05816499
What this trial is testing

Cadonilimab in Patients (Pts) With Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
NSCLC Stage IVNSCLC Stage IIIBNSCLC Stage IIIC
Shanghai Chest Hospital 50
Not applicableStudy completedNCT01416688
What this trial is testing

S1013: Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cancer Receiving Cetuximab, Panitumumab, or Erlotinib Hydrochloride

Who this might be right for
Colorectal CancerDermatologic ComplicationsLung Cancer+1 more
SWOG Cancer Research Network 146
Not applicableStudy completedNCT01741636
What this trial is testing

Survivorship Care Planning in Patients With Colorectal or Non-Small Cell Lung Cancer

Who this might be right for
Stage I Colon CancerStage I Rectal CancerStage IA Non-small Cell Lung Cancer+17 more
City of Hope Medical Center 30
Large-scale testing (Phase 3)Looking for participantsNCT06041776
What this trial is testing

Adjuvant Befotertinib in Stage IB-IIIB Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations

Who this might be right for
Non-Small Cell Lung CancerEGFR Sensitive MutationAdjuvant Therapy
Betta Pharmaceuticals Co., Ltd. 570
Large-scale testing (Phase 3)Looking for participantsNCT07010419
What this trial is testing

Assess the Efficacy and Safety of Firmonertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB - IIIB NSCLC With Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations, Following Complete Surgical Resection With or Without Adjuvant Chemotherapy（FIRMOST）

Who this might be right for
NSCLCAdjuvant Treatment
Allist Pharmaceuticals, Inc. 338
Not applicableEnded earlyNCT02895503
What this trial is testing

Yoga in Improving Quality of Life in Patients With Non-small Cell Lung Cancer Undergoing Treatment

Who this might be right for
Non-small Cell Lung CancerRecurrent Non-Small Cell Lung Carcinoma
Virginia Commonwealth University 1
Testing effectiveness (Phase 2)Looking for participantsNCT07039656
What this trial is testing

Toripalimab Combined With Chemotherapy as Adjuvant Therapy for Non-small Cell Lung Cancer With or Without Prior Neoadjuvant Therapy

Who this might be right for
Stage IB-IIIB NSCLCStage IIB-III NSCLC
Wen-zhao ZHONG 211
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Load More Results